INTERNATIONAL PATENT: BOEHRINGER INGELHEIM INTERNATIONAL GMBH FILES APPLICATION FOR "SOLUBLE GLP1/GIP/NPY2 RECEPTOR TRIPLE AGONISTS"

GENEVA, Dec. 22 -- BOEHRINGER INGELHEIM INTERNATIONAL GMBH (Binger Strasse 17355216 INGELHEIM AM RHEIN) filed a patent application (PCT/EP2025/066341) for "SOLUBLE GLP1/GIP/NPY2 RECEPTOR TRIPLE AGONISTS" on Jun 12, 2025. With publication no. WO/2025/257294, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HAEBEL, Peter Wilhelm (Boehringer Ingelheim International GmbHGlobal PatentsBinger Strasse 17355216 INGELHEIM AM RHEIN), MADSEN, Charlotte Stahl (Ved Gershoj 192760 Malov), MURRAY, Anthony (Kollegieheven 52920 Charlottenl...